High levels of hypoxia in xenografted pancreatic tumors predict aggressive growth and enhanced metastatic potential. Treatment efficacy of the hypoxia-targeting prodrug TH-302 depended on level of hypoxia and tumor growth rate. Results provide additional...
Filed under: Press Releases, radiation, Research, Treatment, Conference, Cancer, Media Materials, AACR, American Association for Cancer Research, pancreatic cancer, tumor growth, preclinical studies, hypoxia, Pancreatic Cancer: Progress and Challenges, TH-302, Dr. Ines Lohse